The Clorox (CLX) Receives Daily Media Sentiment Score of 0.12

Press coverage about The Clorox (NYSE:CLX) has been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. The Clorox earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.721409824365 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

A number of equities analysts have commented on CLX shares. Wells Fargo & Co decreased their price objective on shares of The Clorox from $140.00 to $130.00 and set a “market perform” rating for the company in a report on Thursday, April 19th. Morgan Stanley downgraded shares of The Clorox from an “equal weight” rating to an “underweight” rating and decreased their price objective for the stock from $126.72 to $116.00 in a report on Thursday, April 19th. They noted that the move was a valuation call. Zacks Investment Research raised shares of The Clorox from a “sell” rating to a “hold” rating in a report on Tuesday, May 8th. ValuEngine downgraded shares of The Clorox from a “hold” rating to a “sell” rating in a report on Saturday, April 21st. Finally, Citigroup decreased their price objective on shares of The Clorox from $139.00 to $126.00 and set a “neutral” rating for the company in a report on Friday, May 4th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $130.98.

CLX stock traded up $0.25 during mid-day trading on Thursday, reaching $119.69. The company had a trading volume of 1,028,212 shares, compared to its average volume of 1,225,167. The company has a debt-to-equity ratio of 2.14, a quick ratio of 0.93 and a current ratio of 1.18. The stock has a market capitalization of $15.48 billion, a price-to-earnings ratio of 22.37, a PEG ratio of 2.71 and a beta of 0.37. The Clorox has a one year low of $113.57 and a one year high of $150.40.

The Clorox (NYSE:CLX) last posted its earnings results on Wednesday, May 2nd. The company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. The company had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.51 billion. The Clorox had a return on equity of 107.93% and a net margin of 13.27%. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period last year, the business posted $1.31 earnings per share. analysts predict that The Clorox will post 5.66 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, August 17th. Shareholders of record on Wednesday, August 1st will be paid a $0.96 dividend. This represents a $3.84 dividend on an annualized basis and a yield of 3.21%. The ex-dividend date is Tuesday, July 31st. The Clorox’s payout ratio is 71.78%.

About The Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.

Insider Buying and Selling by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with's FREE daily email newsletter.

Leave a Reply